在慢性病中绘制心脏重塑的地图
Nadine Kaesler1,2, Mingbo Cheng3, James Nagai3
1Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Disease, University Hospital of the RWTH Aachen, Aachen, Germany.
Science advances
|November 24, 2023
概括
慢性病 (CKD) 通过TNFα等尿素毒素引起心脏重塑,导致心力衰竭. 针对这些毒素,例如TNFα抑制,可能会改善CKD患者的心脏健康.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
背景情况:
- 晚期慢性病 (CKD) 与突发心脏病死亡和心力衰竭的高死亡率有关.
- 在CKD中心脏改造背后的分子和细胞机制仍然不太了解.
- 了解这些机制对于开发有效的治疗策略至关重要.
研究的目的:
- 在CKD中剖析心脏重塑的分子和细胞机制,使用公正的方法.
- 确定关键的分子参与者和参与CKD相关心脏变化的细胞通路.
- 探索潜在的治疗目标,以减轻心脏重塑在CKD.
主要方法:
- 单核RNA测序在两种CKD小鼠模型的左心室组织上进行.
- 对细胞对尿素毒素的反应进行了综合分析.
- 在体外和体内实验被用来验证发现,包括TNFα抑制.
主要成果:
- 慢性瘤诱导了心肌细胞的过度缩反应,其特点是压力信号和代谢变化,由可溶性尿素因子驱动.
- 观察到纤维细胞到肌纤维细胞的分化和心血管系统的显著变化,表明炎症和功能障碍.
- 内末林-1和甲基素与毛细血管功能障碍有关,而TNFα被确定为心肌细胞增大的一个驱动因素,这被证实并通过TNFα抑制得到改善.
结论:
- 尿素毒素通过不同的细胞通路显著促进CKD中的心脏重塑.
- 在CKD的背景下,TNFα在驱动心肌细胞缩方面发挥着关键作用.
- 向特定的尿素毒素,如TNFα,是改善心脏重塑和改善CKD患者的结果的有希望的治疗途径.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: Diuretics
398
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
398